Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.45 |
| ▸ | RARB | P10826 | 5/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11213206 | 0.89 | CYP3A4 (0.52) | TP53TSHRPLA2G4BCYP3A4CYP2C8 | |
| SCHEMBL11209754 | 0.89 | CYP3A4 (0.57) | PLA2G2ATP53TSHRPLA2G4BCYP3A4 | |
| SCHEMBL8552683 | 0.89 | CYP3A4 (0.47) | CYP3A4CYP2C8CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL10929547 | 0.88 | FYN (0.54) | CYP2C9TBXA2R | |
| SCHEMBL11072230 | 0.88 | CYP3A4 (0.56) | PLA2G2ACYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL11072113 | 0.88 | CYP3A4 (0.50) | TP53TSHRCYP3A4CYP2C8CYP2D6 | |
| SCHEMBL8553934 | 0.87 | CYP3A4 (0.46) | CYP3A4CYP2C8CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL8553460 | 0.87 | TBXA2R (0.45) | CYP3A4CYP2C8CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL8552795 | 0.83 | KDM4E (0.42) | CYP3A4CYP2C8CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL24214088 | 0.82 | ALDH1A1 (0.49) | CYP2C19TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5262678-A | — | — | None | — | — | JP | disclosed |
| EP-0546338-B1 | Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method | CANON KK (JP) | 1998-02-04 | — | — | EP | disclosed |
| US-5385692-A | Improved response | CANON KABUSHIKI KAISHA (JP) | 1995-01-31 | — | — | US | disclosed |
| JP-H05262678-A | LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME, LIQUID CRYSTAL ELEMENT HAVING THE SAME, METHOD FOR DISPLAYING AND DISPLAY DEVICE USING THE SAME | CANON INC | 1993-10-12 | — | — | JP | disclosed |
| EP-0546338-A1 | Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method | CANON KABUSHIKI KAISHA (JP) | 1993-06-16 | — | — | EP | disclosed |